For the Quarter Ending March 2026
Salbutamol Sulphate Prices in North America
- In United States, the Salbutamol Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- During March 2026, CPI reached 3.3% and PPI hit 4.0%, elevating the Salbutamol Sulphate Production Cost Trend.
- The Manufacturing Index expanded and industrial production grew 0.7% in March 2026, supporting stable pharmaceutical packaging.
- Retail sales grew 4.0% and unemployment hit 4.3% in March 2026, sustaining the Salbutamol Sulphate Demand Outlook.
- Consumer confidence reached a 91.8 index in March 2026, ensuring consistent patient adherence for respiratory medication prescriptions.
- Salbutamol Sulphate demand surged in Jan 2026 as flu hospitalizations reached the highest level in three decades.
- Phenol, benzene, and propylene feedstock costs surged during Q1 2026, directly increasing upstream chemical synthesis processing expenses.
- Tight hospital inventories and constrained supply chains supported an elevated Salbutamol Sulphate Price Forecast in Q1 2026.
- Crude oil prices surged in Q1 2026, while natural gas prices dropped due to milder February 2026 temperatures.
Why did the price of Salbutamol Sulphate change in March 2026 in North America?
- Unprecedented flu activity and elevated emergency department visits surged Salbutamol Sulphate demand in Jan 2026.
- Phenol, benzene, and propylene feedstock costs faced severe upward pressure throughout the Q1 2026 period.
- Constrained supply chains and tight hospital nebulizer inventories restricted overall product availability during Q1 2026.
Salbutamol Sulphate Prices in APAC
- In China, the Salbutamol Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream precursor costs.
- The Salbutamol Sulphate Production Cost Trend increased in March 2026 as the PPI rose by 0.5%.
- A 1.0% CPI increase in March 2026 supported a steady Salbutamol Sulphate Demand Outlook for respiratory pharmaceuticals.
- Industrial production grew by 5.7% in March 2026, ensuring high-volume supply availability for bulk API synthesis.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, driving consumer preference toward generic medications.
- Consumer confidence hit 91.6 in February 2026, limiting pricing power for downstream drug manufacturers in the market.
- The Manufacturing Index expanded in March 2026, reflecting robust activity and strong order books for pharmaceutical sectors.
- Upstream phenol feedstock costs surged in Q1 2026 due to rising benzene and propylene expenses.
- Respiratory drug manufacturing strengthened in Q1 2026, elevating the Salbutamol Sulphate Price Forecast for the quarter.
Why did the price of Salbutamol Sulphate change in March 2026 in APAC?
- Upstream phenol feedstock costs surged in Q1 2026, significantly driving up chemical synthesis production expenses.
- Pharmaceutical demand for respiratory applications strengthened in March 2026, supporting strong upward market price momentum.
- Domestic phenol supply tightened during plant maintenance activities in Q1 2026, restricting raw material availability.
Salbutamol Sulphate Prices in Europe
- In Germany, the Salbutamol Sulphate Price Index rose quarter-over-quarter in Q1 2026, driven by surging pharmaceutical manufacturing costs.
- In March 2026, a 2.7% CPI increase elevated operational costs, pushing the Salbutamol Sulphate Price Index upward.
- Despite a -0.2% PPI decline in March 2026, the Salbutamol Sulphate Production Cost Trend remained elevated overall.
- The Manufacturing Index expanded in March 2026, ensuring stable supply chains for Salbutamol Sulphate API processing.
- Stagnant industrial production at 0.0% in February 2026 reflected flat baseline manufacturing activity for Salbutamol Sulphate formulation.
- Modest retail sales growth of 0.7% in February 2026 supported a positive Salbutamol Sulphate Demand Outlook.
- A stable 4.2% unemployment rate in February 2026 sustained end-use demand for Salbutamol Sulphate respiratory treatments.
- Negative consumer confidence at -24.7 in March 2026 indicated cautious spending, slightly impacting the Salbutamol Sulphate Price Forecast.
- International export shipments of European-produced Salbutamol Sulphate remained active and stabilized across global markets in February 2026.
Why did the price of Salbutamol Sulphate change in March 2026 in Europe?
- Pharmaceutical manufacturing producer costs surged in February 2026, directly increasing overall Salbutamol Sulphate synthesis expenses.
- Consumer prices for medicines strengthened in February 2026, supporting upward market momentum for Salbutamol Sulphate.
- Natural gas feedstock prices weakened in February 2026, partially offsetting broader pharmaceutical production cost increases.
For the Quarter Ending December 2025
Salbutamol Sulphate Prices in North America
- In the United States, the Salbutamol Sulphate Price Index rose quarter-over-quarter in Q4 2025, driven by increased production costs.
- Salbutamol Sulphate production costs increased due to a 3.0% year-over-year PPI rise in November 2025.
- Demand for Salbutamol Sulphate expanded in Q4 2025, supported by FDA approvals in the respiratory drug market.
- Industrial production increased by 2.0% year-over-year in December 2025, indicating stable supply chains.
- Consumer Price Index rose 2.7% year-over-year in December 2025, increasing operational and labor expenses.
- North American chemical producers benefited from low-cost feedstock in November 2025, mitigating cost pressures.
- Global trade growth decelerated sharply in the final months of 2025 due to tariffs.
- The unemployment rate of 4.4% in December 2025 indicated a tight labor market, increasing labor costs.
Why did the price of Salbutamol Sulphate change in December 2025 in North America?
- Rising input costs, with PPI up 3.0% year-over-year in November 2025, elevated production expenses.
- Strong demand drivers, including FDA approvals for respiratory drugs in Q4 2025, supported market expansion.
- General inflation, with CPI rising 2.7% year-over-year in December 2025, increased overall operational costs.
Salbutamol Sulphate Prices in APAC
- In China, the Salbutamol Sulphate Price Index fell in Q4 2025, driven by declining production costs.
- Production costs decreased as the Producer Price Index declined by -1.9% year-on-year in December 2025.
- Persistent overcapacity in China's chemical sector in October 2025 pressured chemical input prices downward.
- Demand for Salbutamol Sulphate was supported by robust pharmaceutical industry growth in China during 2025.
- Industrial Production increased by 5.2% year-on-year in December 2025, indicating a healthy manufacturing environment.
- Domestic consumer demand remained sluggish in China during Q4 2025, with retail sales up 0.9% year-on-year.
- Healthcare industry financing showed strong recovery in Q4 2025, supporting pharmaceutical sector investment.
- China's Manufacturing Index expanded in December 2025, reflecting broader industrial sector growth.
Why did the price of Salbutamol Sulphate change in December 2025 in APAC?
- Producer Price Index declined by -1.9% year-on-year in December 2025, reducing Salbutamol Sulphate production costs.
- Persistent overcapacity in China's chemical sector in October 2025 created downward pressure on input prices.
- Sluggish domestic consumer demand in Q4 2025, with retail sales up 0.9% year-on-year, tempered overall demand.
Salbutamol Sulphate Prices in Europe
- In Germany, the Salbutamol Sulphate Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices.
- Salbutamol Sulphate production costs decreased in December 2025 as the Producer Price Index declined by 2.5% year-over-year.
- Demand for Salbutamol Sulphate was supported by an increase in German pharmaceuticals output during 2025.
- The Manufacturing Index contracted in December 2025, indicating a slowdown in overall economic activity.
- Consumer Price Index rose by 1.8% year-over-year in December 2025, affecting operational expenses.
- Industrial production grew by 0.8% in October 2025, providing a stable supply chain; retail sales grew 1.1% in November 2025.
- Unemployment was 6.2% in December 2025, while consumer confidence remained low at -17.5.
- European natural gas prices stabilized in Q4 2025, with slight easing observed in November.
- The Salbutamol Sulphate Price Forecast suggests continued pressure from competitive foreign imports in Q4 2025.
Why did the price of Salbutamol Sulphate change in December 2025 in Europe?
- Producer Price Index declined by 2.5% in December 2025, reducing Salbutamol Sulphate input costs.
- Increased competitive pressure from abroad led German chemical companies to adjust prices downwards in October 2025.
- Weak domestic and export orders for German chemical industry in Q4 2025 impacted demand.
For the Quarter Ending September 2025
North America
- In United States, the Salbutamol Sulphate Price Index remained stable in Q3 2025, influenced by mixed macroeconomic signals.
- Production costs rose due to a 2.6% year-over-year PPI increase in August 2025, reflecting higher input expenses.
- Demand outlook supported by 5.42% retail sales rise and 4.3% unemployment rate in September 2025.
- Declining consumer confidence to 94.2 in September 2025 suggested potential future constraints on healthcare spending.
- Chemical manufacturing activity contracted in Q3 2025, despite a marginal 0.1% industrial production increase in September 2025.
- Feedstock benzene costs strengthened in July and August 2025, elevating phenol production expenses for Salbutamol Sulphate.
- US pharmaceutical exports decreased year-on-year in July 2025, while imports increased, expanding the sector's trade deficit.
- Salbutamol Sulphate price forecast stable, with 3.0% CPI in September 2025 balanced by easing phenol prices.
Why did the price of Salbutamol Sulphate change in September 2025 in North America?
- Phenol prices eased in September 2025 due to elevated inventories, moderating Salbutamol Sulphate production costs.
- A 3.0% year-over-year CPI increase in September 2025 indicated general inflationary pressure on operational expenses.
- Robust retail sales, up 5.42% year-over-year in September 2025, supported consumer affordability.
APAC
- In China, the Salbutamol Sulphate Price Index fell quarter-over-quarter in Q3 2025, due to deflationary pressures and persistent oversupply.
- Salbutamol Sulphate production costs faced downward pressure in September 2025, as producer prices declined 2.3% year-over-year.
- Demand for Salbutamol Sulphate is supported by 3.0% retail sales growth in September 2025 and expanding healthcare.
- China's pharmaceutical market saw robust growth in 2025, driven by an aging population and rising chronic diseases.
- Petrochemical feedstock prices for Salbutamol Sulphate held steady throughout Q3 2025 amid global overcapacity.
- The Manufacturing Index contracted in September 2025, reflecting reduced industrial activity affecting supply chains.
- Industrial production, however, expanded 6.5% year-over-year in September 2025, indicating growth in manufacturing.
- New export orders for China's manufacturing sector strengthened in September 2025, increasing after several months.
- Consumer confidence remained low at 89.6 in September 2025, with 5.2% unemployment, dampening spending.
- Government policy in September 2025 aims to optimize capacity and foster high-value specialty chemicals.
Why did the price of Salbutamol Sulphate change in September 2025 in APAC?
- Consumer Price Index declined 0.3% in September 2025, indicating deflationary pressures and price erosion.
- Producer Price Index fell 2.3% in September 2025, suggesting lower input costs for production.
- Low consumer confidence at 89.6 and 5.2% unemployment dampened pharmaceutical demand.
Europe
- In Germany, the Salbutamol Sulphate Price Index rose quarter-over-quarter in Q3 2025, driven by elevated raw material and operational costs.
- Salbutamol Sulphate production costs faced upward pressure from a 2.4% CPI increase in September 2025, impacting operations.
- Producer prices fell 1.7% in September 2025 due to lower energy costs, partially offsetting production burdens.
- Demand for pharmaceutical products, including Salbutamol Sulphate, strengthened in Germany during Q3 2025.
- The Manufacturing Index contracted in Q3 2025, indicating a broader slowdown affecting Salbutamol Sulphate supply chains.
- German industrial production declined 1.0% in September 2025, indirectly impacting non-API components and logistics.
- Retail sales increased 0.2% in September 2025, suggesting a stable consumer economy supporting healthcare spending.
- The unemployment rate remained stable at 6.3% in September 2025, potentially straining healthcare access and funding.
- European natural gas spot prices eased in Q3 2025, reducing energy feedstock costs for Salbutamol Sulphate manufacturing.
Why did the price of Salbutamol Sulphate change in September 2025 in Europe?
- Elevated raw material costs and 2.4% CPI increase in September 2025 pressured Salbutamol Sulphate prices.
- Easing natural gas prices and 1.7% PPI decrease in September 2025 partially offset production costs.
- Strengthening pharmaceutical demand in Q3 2025 supported Salbutamol Sulphate prices despite industrial weakness.
